Dianthus Therapeutics (DNTH) Receivables (2022 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Receivables came in at $102000.0 in Q4 2025, down 93.65% year-on-year from $1.6 million in Q4 2024, and down 98.0% quarter-over-quarter from $5.1 million in Q3 2025.
Dianthus Therapeutics (DNTH) Receivables (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Receivables history runs 4 years deep, the most recent figure standing at $102000.0 for Q4 2025.
- On a quarterly basis, Receivables fell 93.65% year-over-year to $102000.0 in Q4 2025; TTM through Dec 2025 was $102000.0, a 93.65% decrease from a year earlier, with the FY2025 full-year figure at $102000.0, down 93.65% from the prior year.
- Receivables slipped to $102000.0 in Q4 2025 per DNTH's latest filing, from $5.1 million in the prior quarter.
- Across five years, Receivables topped out at $5.6 million in Q4 2022 and bottomed at $102000.0 in Q4 2025.
- The 4-year median for Receivables is $1.3 million (2025), against an average of $1.8 million.
- Across the five-year window, Receivables soared 259.52% in 2024 and slumped 93.65% in 2025, its largest moves.
- Year by year, Receivables stood at $5.6 million in 2022, then sank by 91.07% to $500000.0 in 2023, then jumped by 221.4% to $1.6 million in 2024, then plunged by 93.65% to $102000.0 in 2025.
- Per Business Quant, the three latest DNTH Receivables figures stand at $102000.0 (Q4 2025), $5.1 million (Q3 2025), and $139000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | 102,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 835,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 751,000.00 |
| Dec 31, 2022 | 5.60 Mn |